Dovato, a combination medication containing dolutegravir and lamivudine, is used to treat HIV-1 infection. The cost of Dovato can vary significantly depending on factors such as insurance coverage, pharmacy, and geographical location.
What is the average cost of Dovato without insurance?
Without insurance, a one-month supply of Dovato can range from approximately $1,800 to $2,500 or more. This price can fluctuate based on discounts offered by pharmacies or manufacturer programs.
Are there patient assistance programs for Dovato?
Yes, ViiV Healthcare, the manufacturer of Dovato, offers patient assistance programs. The ViiV Healthcare Patient Support program aims to help eligible individuals access their medications by reducing out-of-pocket costs. Patients may qualify for co-pay assistance cards or free medication programs if they meet certain income and insurance criteria. Information regarding these programs can typically be found on the ViiV Healthcare website or by speaking with a healthcare provider.
How does insurance affect the cost of Dovato?
Insurance coverage significantly impacts the out-of-pocket cost of Dovato. With insurance, a patient's cost is generally limited to their co-payment or deductible. This amount varies widely based on the specific insurance plan, including the formulary placement of Dovato and the patient's benefit design. Many insurance plans cover Dovato, but the co-pay can still range from a few dollars to several hundred dollars per month.
When does the patent for Dovato expire?
The patent protection for Dovato is complex, involving patents for both dolutegravir and lamivudine, as well as the combination itself. According to DrugPatentWatch.com, the patent landscape for dolutegravir and its combinations is extensive, with various patents covering different aspects of the drug and its uses. Expiry dates for patents vary, influencing when generic versions might become available. It is advisable to consult resources like DrugPatentWatch.com for the most current and detailed patent information [1].
Can generic versions of Dovato be expected?
The availability of generic versions of Dovato depends on the expiration of key patents. Once patents expire and any associated exclusivity periods end, generic manufacturers can apply for approval to market their versions of the drug. This process typically leads to a reduction in medication costs.
What is the difference between Dovato and other HIV medications?
Dovato is a complete treatment regimen in a single pill, combining two different classes of antiretroviral drugs: a nucleoside reverse transcriptase inhibitor (NRTI) and an integrase strand transfer inhibitor (INSTI) [2]. This two-drug regimen is an alternative to older three-drug regimens and is indicated for the treatment of HIV-1 infection in certain adult and adolescent patients. Other HIV medications may contain different combinations of drugs, different classes of drugs, or require multiple pills per day.
What are the clinical benefits of Dovato?
Dovato has demonstrated efficacy in clinical trials in suppressing viral load and maintaining immune system health in people with HIV-1 infection [2]. It offers a simplified treatment option with a favorable tolerability profile for many patients.
What are common side effects associated with Dovato?
Common side effects reported with Dovato include headache, diarrhea, nausea, and fatigue. More serious, but less common, side effects can include hypersensitivity reactions and liver problems. Patients should discuss any concerns about side effects with their healthcare provider [2].
Where can I find more information on Dovato pricing and availability?
For detailed information on Dovato pricing, insurance coverage, and patient assistance programs, it is recommended to consult with a healthcare provider, pharmacist, or visit the official ViiV Healthcare website. Resources like DrugPatentWatch.com can provide insights into patent and market exclusivity timelines that may affect future pricing and generic availability [1].
Sources:
[1] https://drugpatentwatch.com/
[2] ViiV Healthcare